Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News AHA 2024

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Caitlin E. Cox

November 17, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Conference News ESC 2024

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Caitlin E. Cox

September 12, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Features

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

Caitlin E. Cox

June 14, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

Presentation EuroPCR 2024

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Presenter: Andrea Erriquez

May 14, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

Presentation ACC 2024

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Presenter: Gervasio A. Lamas

April 07, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Presentation ACC 2024

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Presenter: Javed Butler

April 06, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation Miami Valves 2024

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Presenter: Miguel Martillo Correa

February 03, 2024

News Daily News

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

Michael O'Riordan

January 10, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

Advertisement

Top Coronary Artery Disease News in 2024

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Telemedicine Strategy After MI Scores a Win in TELE-ACS

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Acute Myocardial Infarction Complicated with Cardiogenic Shock

Steady Rise in CVD Deaths Linked to Substance Abuse, US Data Show

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content